Clinical trial
A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms
NCT06223880 is registered in ClinicalTrials.gov with Axsome Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Active-controlled Study of AXS-05 for the Prevention of Relapse of Depressive Symptoms
- Lead sponsor
- Axsome Therapeutics, Inc.
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- December 27, 2023
- Completion date
- March 31, 2026
- Enrollment
- 350 (estimated)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.